Interestingly, we found that most of the CpG sites (out of the 11 CpG sites) analyzed for NOS1AP showed significant hyper-methylation in smokers and COPD groups compared to non-smokers. This evidence concerns the gene NOS1AP and chronic obstructive pulmonary disease.